Coronary stent infection is a rare but life-threatening complication that can present with late coronary artery perforation and pericardial abscess, requiring high clinical suspicion and urgent surgical management.
Answers are grounded in this paper and cite their sources.
Pericardial abscess may complicate coronary perforation; extends known sequelae but leaves optimal management open.
HomeCirculation: Cardiovascular InterventionsVol. 11, No. 2Coronary Artery Perforation Complicated by Pericardial Abscess Formation Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBCoronary Artery Perforation Complicated by Pericardial Abscess FormationA Clinical Dilemma Laura J. Davidson, MD and Mark J. Ricciardi, MD Laura J. DavidsonLaura J. Davidson From the Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL. and Mark J. RicciardiMark J. Ricciardi From the Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL. Originally published5 Feb 2018https://doi.org/10.1161/CIRCINTERVENTIONS.117.005917Circulation: Cardiovascular Interventions. 2018;11:e005917Coronary artery perforation is a rare complication of percutaneous coronary intervention, which occurs in 0.1% to 3% of cases.1 An infrequent cause of coronary artery perforation is stent infection, 80% of which are because of Staphylococcal aureus.2 This is a case of a S. aureus pericardial abscess discovered in the setting of a late left anterior descending (LAD) coronary artery perforation and the potential explanations for this rare presentation. Reports of sepsis after coronary stent implantation, leading to coronary artery aneurysm formation or perforation,3,4 and of purulent pericarditis after percutaneous coronary intervention are exceedingly rare.5–7 This is a rare first report of a pericardial abscess found in conjunction with a perforated coronary artery.Case PresentationA 75-year-old man with a history of hypertension and hyperlipidemia presented to another hospital with upper back pain and electrocardiographic evidence for an ST-segment–elevation myocardial infarction. Coronary angiography revealed a proximal 90% occluded calcified LAD lesion, which was treated with a 2.5×18 mm drug-eluting stent (Figure 1), aspirin, and ticagrelor. A transthoracic echocardiogram demonstrated an ejection fraction of 50% and anterior wall hypokinesis with no significant valvular lesions. Postprocedural shortness of breath developed and was attributed to ticagrelor, which was replaced with clopidogrel. Despite this, he continued to complain of shortness of breath. Nine days after initial presentation with an ST-segment–elevation myocardial infarction, the patient returned to the same hospital for evaluation of his shortness of breath, and a repeat echocardiogram was performed that demonstrated a large pericardial effusion. Pericardiocentesis produced 500 cc of bloody fluid. His shortness of breath improved, and he was discharged home.Download figureDownload PowerPointFigure 1. A, A 90% proximal, calcified left anterior descending lesion was seen on the initial coronary angiogram. B, The lesion was successfully treated with a 2.5×18 mm drug-eluting stent.Several days later, a rash on his upper and lower extremities developed and was attributed to a clopidogrel drug reaction. He was, therefore, switched back to ticagrelor. The rash did not resolve, and 2 weeks after his pericardiocentesis, he was readmitted with progressive shortness of breath.At this time, he was transferred to our institution for further management. On arrival to our hospital, he complained primarily of shortness of breath. His blood pressure was 117/85, his pulse was 83 beats per minute, with an oxygen saturation of 98% on 2 L nasal cannula. Scattered petechiae and palpable purpura with central necrosis were evident on the dorsum of his hands and feet. He had decreased breath sounds at the left lung base. His electrocardiogram showed normal conduction and no ischemic changes. Laboratory data revealed a mild leukocytosis, a hemoglobin of 10 g/dL, normal renal function, and a mild transaminitis.DiscussionDr Davidson: The patient has just arrived at your institution, what initial work up would you pursue at this juncture?Dr Ricciardi: My initial tests of choice are a repeat echocardiogram and chest x-ray, given his progressive shortness of breath and concern for another pericardial effusion. A pericardial effusion requiring drainage following stent placement is concerning for coronary artery perforation and therefore requires further, immediate investigation. However, on review of the angiogram performed at the time of the patient's ST-segment elevation myocardial infarction, the LAD stent does not appear oversized, making perforation less likely.Dr Davidson: The echocardiogram was performed and demonstrated reaccumulation of pericardial fluid posteriorly (Figure 2), without evidence of hemodynamic compromise. There was also evidence of apical hypokinesis, which is a different distribution of wall motion abnormalities compared to the anterior hypokinesis seen immediately following his ST-segment elevation myocardial infarction presentation. A chest x-ray demonstrated a left-sided pleural effusion. What steps would you take at this point?Download figureDownload PowerPointFigure 2. An echocardiogram revealed a pericardial fluid collection, measuring 3.2 cm and causing indentation of the left ventricle. Apical hypokinesis was also observed.Dr Ricciardi: Given that there is no evidence of hemodynamic compromise on the echo or any clinical signs of cardiac tamponade, urgent drainage of the fluid is not necessary at this time. The left-sided pleural effusion is an interesting finding, which should be explored further, as the patient has no clinical signs of heart failure and the asymmetry of the effusion could indicate an infectious etiology, especially with his leukocytosis. Another consideration is extravasation of fluid from the pericardium into the pleural space. It is notable that the patient is anemic, which could be due to bleeding into the pericardial and pleural space. I recommend further characterizing the effusion with a computed tomography (CT) scan of the chest, obtaining blood cultures, and evaluating the rash with a skin biopsy.Dr Davidson: Pathologic examination of the biopsied skin lesions was consistent with leukocytoclastic vasculitis and not a drug reaction. What does this indicate to you?Dr Ricciardi: Hypersensitivity reactions to clopidogrel are seen in up to 5% of patients, which most commonly manifest as a rash.8 Therefore, switching the patient to an alternative antiplatelet agent in the setting of a rash is a reasonable first step in diagnosis and management. Additionally, shortness of breath can be observed in 10% to 20% of patients who take ticagrelor.9 However, patients taking ticagrelor have known coronary artery disease and potentially other cardiac disease, and shortness of breath should be merely a diagnosis of exclusion after all other potential etiologies of a patient's shortness of breath have been explored. Another consideration in a patient with recent drug-eluting stent implantation is an adverse reaction to the stent polymer or drug.10 In this patient, the suspicion for adverse drug reactions is less likely and the biopsy finding of leukocytoclastic vasculitis raises greater suspicion for an infectious etiology of his rash, especially in the setting of an abnormal chest x-ray. A chest CT scan is critical at this juncture to evaluate for potential infection.Dr Davidson: A chest CT scan with contrast was ordered. Shortly prior to the CT scan, the patient developed a new left bundle branch block on telemetry but denied any symptoms of chest pain or worsening shortness of breath. The CT scan was negative for a pulmonary embolism but did show extensive ground glass opacities, a loculated pericardial effusion with mass effect, and high attenuation adjacent to the LAD extending into the pericardial effusion, concerning for active hemorrhage (Figure 3). Additionally, compressive atelectasis at the left lung base was noted with a left pleural effusion, which was communicating with the pericardium. His hemoglobin had remained stable since admission. What are your thoughts on the immediate management of this patient?Download figureDownload PowerPointFigure 3. A computed tomographic scan demonstrated high attenuation adjacent to the left anterior descending extending into a loculated, posterior pericardial effusion (solid arrow), which is suspicious for active hemorrhage. The pericardial effusion exhibits mass effect on the left ventricle. Compressive atelectasis at the left lung base is also noted associated with a left pleural effusion (dotted arrow).Dr Ricciardi: While the ground glass opacities certainly raise the suspicion for infection, the concern for active hemorrhage is of more immediate concern. Even though the patient is not showing any clinical signs of cardiac tamponade, it is necessary to evaluate this finding immediately. Additionally, it appears that the pericardial effusion is contiguous with the pleural effusion, raising concern for hemorrhage into the pleural space as well. In light of the left bundle branch block that recently developed, the apical wall motion abnormality, and the CT scan findings, I would recommend urgent coronary angiography to specifically evaluate the LAD and the coronary stent that was recently placed.Dr Davidson: An emergent coronary angiography demonstrated free extravasation of contrast from the LAD consistent with perforation (Figure 4). How would you treat this life-threatening lesion?Download figureDownload PowerPointFigure 4. An emergent coronary angiogram revealed free extravasation of contrast from the left anterior descending, consistent with a perforation.Dr Ricciardi: On review of the coronary angiogram, it is clear that the distal vessel is not opacified on angiography. Therefore, successful placement of a covered stent may not be feasible. The perforation does appear to be at the location of the previously placed LAD stent. Given signs of active hemorrhage, the only viable option at this point is to send the patient to the operating room for surgical correction of the perforated LAD.Dr Davidson: In the operating room, exploration revealed a posterior pericardial abscess, a densely adherent, fibrotic pericardium, and a proximal LAD perforation. Blood from the LAD was freely extravasating into the pericardial space. While in the operating room, blood cultures drawn 1 day prior returned positive for Gram-positive cocci, which subsequently speciated as S. aureus. In spite of his bacteremia, the patient never developed a fever until after surgery. How can we account for the constellation of findings in this case, including a perforated LAD, pericardial effusion and abscess, S. aureus bacteremia, leukocytoclastic vasculitis, and ground glass opacities?Dr Ricciardi: Although unusual, I believe that the most plausible explanation for this patient's unique presentation is a coronary stent infection. Reports of coronary stent infection leading to coronary mycotic aneurysm formation and rupture, as well as reports of purulent pericarditis following drug-eluting stent placement, have been described but rarely rupture and develop purulent pericarditis in the same patient.11 In this case, where both coronary artery rupture and pericardial abscess formation occurred, I hypothesize that an infected stent caused abscess formation within the LAD, leading to rupture and a hemorrhagic pericardial effusion. I believe that the thick and adherent pericardium compressed the perforated vessel, thereby avoiding overt hemopericardium and tamponade. I speculate that the pericardium was subsequently seeded by the bacteria from the infected stent and a pericardial abscess formed. Staphylococcal bacteremia and septic emboli ensued and was manifested by cutaneous leukocytoclastic vasculitis and multifocal pneumonia. As with this patient, coronary stent infections are most often due to S. aureus, further supporting this diagnosis.12 A pericardial effusion in the setting of recent stent placement is always concerning for a perforated coronary artery until proven otherwise.Dr Davidson: Are there any alternative explanations for this constellation of clinical findings?Dr Ricciardi: An alternative explanation for the patient's presentation is coronary perforation as a complication of stent placement resulting in hemorrhagic tamponade. Others have reported pseudoaneurysm formation at the site of stent implantation and subsequent cardiac tamponade.13 While stent infection is a reported cause of coronary pseudoaneurysm, balloon overexpansion and dissection are much more common causes for this complication.14–16 In addition, my review of the patient's initial angiogram showed no evidence of procedural dissection or perforation. This alternative explanation could, therefore, only be plausible if an unrecognized microdissection had occurred leading to the subsequent development of hemorrhagic pericardial effusion. In this scenario, I would presume that the pericardial abscess and systemic infection was the result of instrumentation during the pericardiocentesis.Finally, it is plausible that the patient developed postmyocardial infarction pericarditis and effusion, which was contaminated with S. aureus during pericardiocentesis. Subsequent formation of an abscess cavity could have then eroded into the LAD causing perforation. This seems unlikely given the posterior location of the pericardial abscess, and it does not explain the hemorrhagic nature of the initial pericardial effusion.Dr Davidson: What can we learn from this rare case and apply to other patients in the future?Dr Ricciardi: Although it is a rare complication of DES placement, this case illustrates that diagnosing a pericardial abscess and effusion should raise suspicion for stent infection and possible coronary artery rupture. Likewise, the diagnosis of late coronary artery perforation should prompt suspicion for stent infection and close monitoring for signs of systemic infection.Clinical OutcomeIn the operating room, the abscess was drained, and a left internal mammary artery to distal LAD graft was placed. Antibiotics were started immediately, and the patient was brought to the intensive care unit. Despite recovering well from a cardiovascular perspective, the patient continued to experience the severe systemic S. aureus infection that affected the lungs, pericardium, skin, and blood. He died several days postoperatively because of septic shock.ConclusionsCoronary artery stent infection caused by S. auerus is a rare but often fatal complication of stent implantation. The first case of S. aureus related stent infection was reported in 1993, and since then, at least 23 other cases have been reported (Table).17 Patients typically present with a wide array of symptoms, including fever, constitutional symptoms, chest discomfort, and myocardial infarction. On clinical evaluation, at least half of the patients who present with S. aureus associated stent infection are found to have a mycotic aneurysm or pseudoaneurysm (n=12). Clinical management of the patients with aneurysms and pseudoanuerysms varies and ranges from surgical resection of the aneurysm and stent, covered stent placement, and conservative management with aggressive antibiotic therapy and is individualized based on the clinical stability of patients and their ability to tolerate surgical intervention. However, there are other patients who have presented with different presentations of infection, including pericardial disease and abscess formation. Overall, on reviewing the previous cases of S. aureus sepsis reported post percutaneous coronary intervention, mortality is ≈45%, indicative of a poor prognosis in spite of the best surgical, procedural, and medical attempts made to intervene on this condition. As observed in the case presented, pericardial effusion postpercutaneous coronary intervention should prompt investigation into possible stent infection with associated coronary artery perforation.Table. Staphylococcal Aureus Sepsis Reports After Percutaneous Coronary InterventionPublicationYearPresentation/ComplicationOrganismTreatmentSurvived?Günther et al171993Pericardial empyemaMRSASurgeryYesGrewe et al181999PancarditisMSSAAntibiotics onlyNoRensing et al192000AbscessStaphylococcal AureusAntibiotics onlyYesSankari et al52000Purulent pericarditisMSSASurgeryYesLiu et al202003Mycotic psuedoaneurysm and abscessMSSASurgeryYesGolubev et al212004AbscessMSSASurgeryNoSingh et al222005Mycotic aneurysmMSSASurgeryYesHoffman et al232005AbscessMSSAAntibiotics onlyYesAlfonso et al242005Purulent pericarditisMSSAAntibiotics onlyNoGonda et al32007AbscessMSSASurgeryYesSalinas et al252007Coronary artery aneurysmMRSASurgeryNoKishida et al262007Mycotic aneurysmS. aureusSurgeryYesJang et al272007Abscess and pseudoaneurysmS. aureusSurgeryYesSchoenkerman and Lundstrom112009Mycotic aneurysm and coronary ruptureS. aureusAntibiotics onlyNoSchoenkerman and Lundstrom112009Mycotic aneurysm and coronary ruptureS. aureusSurgeryYesSchoenkerman and Lundstrom112009Purulent pericardial effusionMRSAAntibiotics onlyNoWu et al22010Ruptured coronary artery and pseudoaneurysmMRSAStent graftYesLim et al282011Mycotic pseudoanerysmMRSASurgeryNoElieson et al122012Myocardial ruptureMSSAAntibiotics onlyNoDel Trigo et al292012Mycotic pseudoanuerysmS. aureusSurgeryNoRoubelakis et al302015Coronary artery aneurysm and ruptureMSSASurgeryYesShafer et al312017Coronary fistulaMRSASurgeryNoTakahashi et al322017Coronary aneurysmS. aureusCovered stentsYesMRSA indicates methicillin-resistant Staphylococcal aureus; and MSSA, methicillin-sensitive Staphylococcal aureus.DisclosuresNone.FootnotesCorrespondence to Laura Davidson, MD, Division of Cardiology, Department of Medicine, Northwestern University, 676 N St, Clair Suite 600, Chicago, IL 60611. E-mail [email protected]References1. Eeckhout E, De Palma R. Coronary perforation: an inconvenient complication.JACC Cardiovasc Interv. 2011; 4:96–97. doi: 10.1016/j.jcin.2010.09.021.CrossrefMedlineGoogle Scholar2. Wu EB, Chan WW, Yu CM. Left main stem rupture caused by methicillin resistant Staphylococcus aureus infection of left main stent treated by covered stenting.Int J Cardiol. 2010; 144:e39–e41. doi: 10.1016/j.ijcard.2008.12.106.CrossrefMedlineGoogle Scholar3. Gonda E, Edmundson A, Mann T. Late coronary stent infection: a unique complication after drug-eluting stent implantation.J Invasive Cardiol. 2007; 19:E307–E308.MedlineGoogle Scholar4. Garg RK, Sear JE, Hockstad ES. Spontaneous coronary artery perforation secondary to a sirolimus-eluting stent infection.J Invasive Cardiol. 2007; 19:E303–E306.MedlineGoogle Scholar5. Sankari A, Kumar AN, Kabins S, Chandna H, Lieb D. Staphylococcal pericarditis following percutaneous transluminal coronary angioplasty.Catheter Cardiovasc Interv. 2000; 50:71–73.CrossrefMedlineGoogle Scholar6. Li Y, Xu R, Cai Z, Ma G, Wang L, Chen P, Zhu Z. Acute purulent pericarditis following staged percutaneous coronary intervention for multivessel disease.Herz. 2013; 38:934–937. doi: 10.1007/s00059-013-3766-6.CrossrefMedlineGoogle Scholar7. Onsea K, Herijgers P, Adriaenssens T. Purulent pericarditis and pericardial abscess one year after LAD-stenting.Acta Cardiol. 2011; 66:249–250. doi: 10.2143/AC.66.2.2071259.CrossrefMedlineGoogle Scholar8. Azarbal B, Currier JW. Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?J Am Coll Cardiol. 2006; 47:182–183. doi: 10.1016/j.jacc.2005.09.045.CrossrefMedlineGoogle Scholar9. Parodi G, Storey RF. Dyspnoea management in acute coronary syndrome patients treated with ticagrelor.Eur Heart J Acute Cardiovasc Care. 2015; 4:555–560. doi: 10.1177/2048872614554108.CrossrefMedlineGoogle Scholar10. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.J Am Coll Cardiol. 2006; 47:175–181. doi: 10.1016/j.jacc.2005.07.071.CrossrefMedlineGoogle Scholar11. Schoenkerman AB, Lundstrom RJ. Coronary stent infections: a case series.Catheter Cardiovasc Interv. 2009; 73:74–76. doi: 10.1002/ccd.21804.CrossrefMedlineGoogle Scholar12. Elieson M, Mixon T, Carpenter J. Coronary stent infections: a case report and literature review.Tex Heart Inst J. 2012; 39:884–889.MedlineGoogle Scholar13. Kawai Y, Kitayama M, Akao H, Motoyama A, Tsuchiya T, Kajinami K. A case of coronary rupture and pseudoaneurysm formation after fracture of implanted paclitaxel-eluting stents.Cardiovasc Interv Ther. 2016; 31:231–237. doi: 10.1007/s12928-015-0338-0.CrossrefMedlineGoogle Scholar14. Choi JH, Song BG, Song B, Song YB, Hahn JY, Choi SH, Kim WS, Gwon HC, Lee SH. Catastrophic coronary stent fracture and coronary perforation presenting as cardiogenic shock: a rare but fatal late complication of stenting.Circ Cardiovasc Imaging. 2008; 1:e7–e8. doi: 10.1161/CIRCIMAGING.108.772087.LinkGoogle Scholar15. Brasselet C, Perotin S. Subacute development of a coronary artery pseudoaneurysm after primary angioplasty and stenting for acute myocardial infarction.J Invasive Cardiol. 2003; 15:168–170.MedlineGoogle Scholar16. Lell E, Wehr G, Sechtem U. Delayed development of a coronary artery pseudoaneurysm after angioplasty.Catheter Cardiovasc Interv. 1999; 47:186–190. doi: 10.1002/(SICI)1522-726X(199906)47:2<186::AID-CCD13>3.0.CO;2-J.CrossrefMedlineGoogle Scholar17. Günther HU, Strupp G, Volmar J, von Korn H, Bonzel T, Stegmann T. [Coronary stent implantation: infection and abscess with fatal outcome].Z Kardiol. 1993; 82:521–525.MedlineGoogle Scholar18. Grewe PH, Machraoui A, Deneke T, Müller KM. Suppurative pancarditis: a lethal complication of coronary stent implantation.Heart. 1999; 81:559.CrossrefMedlineGoogle Scholar19. Rensing BJ, van Geuns RJ, Janssen M, Oudkerk M, de Feyter PJ. Stentocarditis.Circulation. 2000; 101:E188–E190.LinkGoogle Scholar20. Liu JC, Cziperle DJ, Kleinman B, Loeb H. Coronary abscess: a complication of stenting.Catheter Cardiovasc Interv. 2003; 58:69–71. doi: 10.1002/ccd.10395.CrossrefMedlineGoogle Scholar21. Golubev N, Schwammenthal E, Di Segni E, Pudil R, Hay I, Feinberg MS. Echocardiographic imaging of coronary artery abscess following stent implantation.Echocardiography. 2004; 21:87–88.CrossrefMedlineGoogle Scholar22. Singh H, Singh C, Aggarwal N, Dugal JS, Kumar A, Luthra M. Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report.Catheter Cardiovasc Interv. 2005; 65:282–285. doi: 10.1002/ccd.20338.CrossrefMedlineGoogle Scholar23. Hoffman M, Baruch R, Kaplan E, Mittelman M, Aviram G, Siegman-Igra Y. Coronary stent bacterial infection with multiple organ septic emboli.Eur J Intern Med. 2005; 16:123–125. doi: 10.1016/j.ejim.2004.10.010.CrossrefMedlineGoogle Scholar24. Alfonso F, Moreno R, Vergas J. Fatal infection after rapamycin eluting coronary stent implantation.Heart. 2005; 91:e51. doi: G, Kumar S, M, coronary a complication of percutaneous coronary Heart Inst J. 2007; K, H, S, H, M, Y, I, Y. surgical of an infected coronary artery after sirolimus-eluting stent Med. 2007; A, J, M, in cardiovascular and caused by an infected paclitaxel-eluting coronary 2007; doi: JW. coronary artery pseudoaneurysm after percutaneous coronary 2011; doi: Trigo M, P, C, E, R, Alfonso F, N, A, L, N, R, late mycotic pseudoaneurysm associated with drug-eluting stent 2012; doi: A, J, G, S, S, M, Coronary artery rupture caused by stent infection: a rare 2015; doi: K, C, A common in an coronary artery stent Staphylococcus aureus doi: S, T, bacterial aneurysms caused by stent Heart J. doi: to M, and A Percutaneous coronary P, I, I, M, M, A, P, J, Wang Y, and the and the of coronary of Cardiovascular 11, 2 Heart Originally elevation myocardial Coronary
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: